SleepCogni bolsters leadership team amid expansion plans

Sheffield-based MedTech innovator SleepCogni has raised £300,000 in a pre-approved EIS bridging round, extending its total funding to £3.9 million. 

This capital will support the company’s mission to secure CE and FCC approvals and expand into the £35 billion global sleep tech market.

Mark Milton-Edwards, a seasoned healthcare leader with experience at Teva Pharmaceuticals and AstraZeneca, joins as non-executive director to drive international commercialisation. Additionally, Joseph Hawkins, instrumental in NHS collaborations and sales, has been promoted to chief operating officer.

Mark said: “I’m excited to join SleepCogni at such a pivotal stage in its journey. The team, led by Richard, has already achieved remarkable success, with their therapy demonstrating significant improvements vs. sham control in a randomised clinical trial setting. 

“The opportunity in sleep is immense, and I believe SleepCogni’s technology has the potential to address a critical global need, changing millions of lives through better sleep. I look forward to contributing my experience in digital health innovation to help unlock the company’s potential for worldwide impact.”

Joseph added: “This next chapter for SleepCogni is incredibly exciting, and I’m honoured to step into the role of COO during this critical phase. 

“Leading our scale-up efforts alongside such talented individuals is a privilege, and I look forward to building something truly impactful. 

“Together, we’re ready to take SleepCogni to new heights and transform sleep health on a global scale.”

Richard Mills, chief executive officer of SleepCogni, said: “I am delighted to strengthen our commercial team and announce this additional funding.

“The continued support from our investors is a testament to their confidence in our mission and the team’s ability to deliver. 

“With a well-rounded executive team featuring experience from global leaders in pharmaceuticals like Teva, healthcare insurance giants such as Aetna, and consumer retail leaders like Apple, we are well-positioned to drive the business forward.

“These leadership appointments underscore SleepCogni’s ambition to revolutionise global sleep health, leveraging cutting-edge technology and a world-class team to address the growing sleep health crisis.

“We welcome Mark Milton-Edwards to the team and celebrate Joseph Hawkins’ well-deserved appointment as COO. 

“Mark’s unparalleled expertise in digital health innovation, combined with Joseph’s energy, vision, and determination, will be instrumental as we prepare to scale rapidly and for international growth. 

“Together, they reinforce our mission to revolutionise sleep health and position SleepCogni as a global leader in insomnia care.”

Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →